Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Human CCL15/MIP-1 delta Antibody, R&D Systems™
GREENER_CHOICE

Catalog No. AF628SP
Change view
Click to view available options
Quantity:
25 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
AF628SP 25 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. AF628SP Supplier R&D Systems Supplier No. AF628SP
Add to Cart
Add to Cart
This item is not returnable. View return policy

Goat Polyclonal Antibody

CCL15/MIP-1 delta Polyclonal specifically detects CCL15/MIP-1 delta in Human samples. It is validated for Western Blot, Neutralization.

Specifications

Antigen CCL15/MIP-1 delta
Applications Western Blot, Neutralization
Classification Polyclonal
Concentration LYOPH
Conjugate Unconjugated
Dilution Western Blot 0.1 ug/mL, Neutralization 0.5-2.5 ug/mL
Formulation Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Accession No. Q16663
Gene Alias chemokine (C-C motif) ligand 15, Chemokine CC-2, HCC-2, HCC-2Lkn-1, leukotactin 1, Leukotactin-1, LKN1, LKN-1, Macrophage inflammatory protein 5, MIP1 delta, MIP-1 delta, MIP5, MIP-5, MIP-5MIP-1d, Mrp-2b, NCC-3, NCC-3MIP-1D, NCC3MRP-2B, new CC chemokine 3, SCYA15member 15, Small-inducible cytokine A15
Gene Symbols CCL15
Host Species Goat
Immunogen E. coli-derived recombinant human CCL15/MIP-1 delta Ser46-Ile113 Accession # Q16663
Purification Method Affinity Purified
Quantity 25 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 6359
Test Specificity Detects human CCL15/MIP-1 delta in direct ELISAs and Western blots. In direct ELISAs and Western blots, a preference for the 68 aa residue isoform over the 92 aa residue isoform of human CCL15/LKN-1 is shown. Additionally, in direct ELISAs, less than 1% cross-reactivity with with rh6Ckine, rhBLC/BCA1, rhENA78, rhEotaxin, rhEotaxin2, rhFractalkine, rhGCP2, rhGRO alpha , rhGRO beta , rhGRO gamma , rhHCC1, rhHCC4, rhI309,rhIL8, rhMCP1, rhMCP2, rhMCP3, rhMCP4, rhMDC, rhMIG, rhMIP1 alpha , rhMIP1 beta , rhMIP3 alpha , rhMIP3 beta , rhMPIF1, rhNAP2, rhPARC, rhRANTES, rhSDF1 alpha ,rhSDF1 beta ,rhTarc, rhTECK, and rhVIC is observed. Neutralizes the biological activity of the 68 aa isoform of recombinant human (rh) CCL15/LKN-1. It will also neutralize the biological activity of the 92 aa residue isoform of rhCCL15/LKN-1 using a 2-fold higher Ig concentration.
Reconstitution Reconstitute at 0.2 mg/mL in sterile PBS.
Target Species Human
Content And Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype IgG
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.